Nonoisotopic Assay for the Presynaptic Choline Transporter Reveals Capacity for Allosteric Modulation of Choline Uptake

[Image: see text] Current therapies to enhance CNS cholinergic function rely primarily on extracellular acetylcholinesterase (AChE) inhibition, a pharmacotherapeutic strategy that produces dose-limiting side effects. The Na(+)-dependent, high-affinity choline transporter (CHT) is an unexplored targe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ruggiero, Alicia M., Wright, Jane, Ferguson, Shawn M., Lewis, Michelle, Emerson, Katie S., Iwamoto, Hideki, Ivy, Michael T., Holmstrand, Ericka C., Ennis, Elizabeth. A., Weaver, C. David, Blakely, Randy D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Chemical Society 2012
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3474274/
https://ncbi.nlm.nih.gov/pubmed/23077721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn3000718
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg